查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1663455

自行給藥市場，按類型、按適應症、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率及預測

Self-administered Drugs Market, By Type, By Indication, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年自我管​​理藥物市場規模價值為 885.146 億美元，2025 年至 2032 年期間的複合年成長率為 7.10%。

自行管理藥品市場-市場動態

慢性病增多

推動自我管理藥物市場發展的一個主要原因是糖尿病、高血壓和自體免疫疾病等慢性疾病的增加。隨著越來越多的患者需要持續用藥，自行服用的藥物變得越來越受歡迎。這些藥品讓患者可以自由、方便地按時服藥，不僅減輕了醫療機構的壓力，也提高了患者的生活品質。此外，隨著社會文化朝著更注重健康的方向轉變，人們對自己的醫療保健變得更加積極主動和了解，這提高了對自我管理選擇的需求和接受度。

自行管理藥物市場 - 關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年），全球市場預計年複合成長率約為 7.10%

根據類型細分，預計注射藥物類別將在 2024 年佔據最大市場佔有率

根據適應症細分，疼痛管理是 2024 年的主要細分市場

從地區來看，北美是 2024 年最大的收入來源

自我管理藥物市場-細分分析：

全球自我管理藥物市場根據類型、適應症和地區進行細分。

根據類型，市場分為注射藥物、經皮藥物和吸入藥物。 2024 年，市場以注射藥物類別為主。隨著生物製劑和生物相似藥的普及，注射型自我給藥越來越受歡迎。這些藥物通常需要精確地給藥和劑量，自動注射器和預填充注射器的新發展使得在家中使用變得更加容易。類風濕性關節炎、多發性硬化症和不同荷爾蒙異常等疾病的治療經常需要注射藥物，患者對自我注射的便利性越來越感興趣。隨著更多患者友善設備和痛苦更少的輸送技術的不斷開發，注射劑市場預計將快速成長。

根據適應症，市場分為糖尿病、心血管、疼痛管理、荷爾蒙替代、骨質疏鬆症和其他。 2024 年，疼痛管理類別佔據主導市場。自我管理藥物市場將疼痛管理作為關鍵的應用領域，表明對治療急性和慢性疼痛的患者友好且有效的方法的需求不斷成長。自行使用的止痛藥，例如外用藥膏、口服藥物和經皮貼劑，在便利性和適應性方面具有顯著優勢，使患者能夠根據需要調整治療過程。預計由於神經性疼痛和關節炎等疾病的發生率不斷上升，自我管理疼痛管理選擇的需求將會增加，這些發展將有助於藥物配方和傳遞系統。

自行管理藥物市場-地理洞察

2024 年，北美在全球自我管理藥物市場佔據主導地位。糖尿病、癌症和骨骼疾病發生率的上升，以及這些疾病患者對自我管理藥物的強烈需求，是推動這項擴張的主要因素。此外，該地區最大經濟體的政府也透過提供保險來支持採用各種自行管理的藥物。美國食品藥物管理局藥品批准數量的增加為新市場參與者的擴張鋪平了道路。例如，美國食品藥物管理局於 2020 年 6 月向禮來公司頒發了額外批准，批准其新型速效胰島素“Lyumjev”，旨在幫助患有 1 型和 2 型糖尿病的成年人改善血糖控制。賴脯胰島素的一個創新版本被稱為 Lyumjev。該公司開發了一種降低 A1C 水平並快速將胰島素吸收到血液中的解決方案。此外，它還能調節糖尿病患者餐後升高的血糖值。這項新適應症無需處方，任何人無論有無症狀都可以進行檢測。

然而，在整個預測期內，預計亞太地區的複合年成長率最快。慢性病的盛行、醫療費用的不斷成長以及醫療服務的日益便捷，都導致該地區對簡單且價格合理的治療方案的需求日益成長。人口老化使得人們更加關注慢性病管理，從而推動了自我管理藥物的使用。此外，由於醫療基礎設施投資和醫療旅遊業的不斷發展，零售藥局也被鼓勵擴大其線上藥品分銷。

自行管理藥物市場-競爭格局：

全球自我管理藥物市場的領導公司包括 Omnicare、SFK Corporation、強生公司、Cardinal Health、McKesson Corporation 等。透過實施合作夥伴關係、協作、區域擴張、併購和新藥開發等多種策略來保持市場競爭力，市場參與者也為其成長做出了重大貢獻。此外，為了提高患者的依從性和開發先進的藥物輸送方法，該領域的企業正在對研發進行大量投資。為了滿足患者和醫療保健專業人員不斷變化的需求，新產品和新技術的不斷推出加劇了市場的競爭。例如，2021年9月，雅培實驗室宣布收購醫療器材製造商Walk Vascular LLC。透過擴大雅培的周邊血管產品組合併推廣血管內治療解決方案，此次收購將加強患者照護。

近期發展

2024 年 2 月：FDA 批准諾華推出 Xolair(R)（奧馬珠單抗）。這種自行注射的藥物可以幫助預防患有 IgE 介導的食物過敏的成人和兒童的過敏性休克和其他過敏反應。

目錄

第 1 章：自行用藥市場概況

  • 研究範圍
  • 市場估計年限

第 2 章：執行摘要

  • 市場片段
    • 自行管理藥物市場片段（按類型）
    • 自行給藥藥物市場片段（依適應症）
    • 各國自行管理藥物市場概況
    • 自行管理藥物市場（按地區）摘要
  • 競爭洞察

第 3 章：自行用藥的主要市場趨勢

  • 自行給藥的市場促進因素
    • 市場促進因素的影響分析
  • 自行給藥的市場限制
    • 市場限制的影響分析
  • 自行給藥的市場機會
  • 自我管理藥物市場未來趨勢

第 4 章：自行給藥產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景規劃
  • 規範架構分析

第 5 章：自行用藥市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • 新冠肺炎疫情後影響分析
    • 表現最佳的市場區隔
    • 邊際成長領域
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：自行用藥市場格局

  • 2024 年自行用藥市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第 7 章：自行管理藥品市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 注射藥物
    • 經皮藥物
    • 吸入藥物

第 8 章：自行管理藥品市場 - 按適應症分類

  • 概述
    • 按適應症細分市場佔有率分析
    • 糖尿病
    • 心血管
    • 疼痛管理
    • 荷爾蒙替代療法
    • 骨質疏鬆症
    • 其他

第 9 章：自行管理藥品市場 - 按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美自我管理藥物主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按類型）
    • 北美市場規模及預測（依適應症分類）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲自行給藥藥物主要製造商
    • 歐洲市場規模及預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模及預測（按適應症）
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區自主給藥藥物主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太市場規模及預測（按類型）
    • 亞太市場規模及預測（依適應症分類）
    • 印度
    • 中國
    • 韓國
    • 日本
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲自行管理藥物的主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模及預測（依適應症分類）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲的自給性藥物主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按適應症分類）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其他地區

第 10 章：主要供應商分析- 自我管理藥品產業

  • 競爭儀錶板
  • 公司簡介
    • Omnicare
    • SFK Corporation
    • Johnson & Johnson
    • Cardinal Health
    • McKesson Corporation
    • Wal-Mart Stores Inc
    • Express Scripts Holding Company
    • CVS Health
    • Walgreens Boots Alliance
    • Rite Aid Corporation
    • Others

第 11 章：360 度分析師視角

第 12 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4610

REPORT HIGHLIGHT

Self-administered Drugs Market size was valued at US$ 88,514.6 Million in 2024, expanding at a CAGR of 7.10% from 2025 to 2032.

Self-administered drugs are those that patients administer to themselves. Both implanted and non-implantable infusion pumps that come into contact with the skin's surface can be used to provide these medications. Self-administered drugs also include over-the-counter, oral, and topical medicines. Patients who lead active lives are looking for medications that will not only save them time but also allow them to stay out of hospitals completely (apart from emergencies). The market for self-administered drugs is expanding as a result of this trend. Policies for reimbursement will also accelerate market expansion. Furthermore, the self-administered drugs market is expected to expand because of factors such as the migration of patient populations to developed nations and the high expense of healthcare, which incentivizes patients to use self-administered drugs.

Self-administered Drugs Market- Market Dynamics

Increase in chronic illnesses

One major reason propelling the self-administered drugs market is the increase in chronic illnesses like diabetes, hypertension, and autoimmune disorders. Drugs that are self-administered are becoming more and more popular as more patients need ongoing medicine. By giving patients the freedom and convenience to take their medications on their schedules, these pharmaceuticals not only lessen the strain on medical institutions but also improve patients' quality of life. Furthermore, individuals are becoming more proactive and knowledgeable about their healthcare due to the cultural shift towards a more health-conscious society, which is raising the demand for and acceptance of self-administered choices.

Self-administered Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.10% over the forecast period (2025-2032)

Based on type segmentation, the Injectable Drugs category was predicted to show maximum market share in the year 2024

Based on indication segmentation, pain management was the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Self-administered Drugs Market- Segmentation Analysis:

The Global Self-administered Drugs Market is segmented on the basis of Type, Indication, and Region.

On the basis of type, the market is segregated into Injectable Drugs, Transdermal Drugs, and Inhaled Drugs. In 2024, the market was dominated by the Injectable Drugs category. With the popularity of biologics and biosimilars, injectable self-administered drugs are becoming more and more popular. These medications frequently need to be administered and dosed precisely, which new developments in auto-injectors and pre-filled syringes have made easier to use at home. Treatments for diseases like rheumatoid arthritis, multiple sclerosis, and different hormonal abnormalities frequently call for injectables, and patients are becoming more and more interested in the ease of self-administration. As more patient-friendly devices and less painful delivery technologies continue to be developed, the injectable market is predicted to increase rapidly.

Based on indication, the market is divided into Diabetes, Cardiovascular, Pain Management, Hormone Replacement, Osteoporosis, and Others. In 2024, the pain management category held a dominant market share. The market for self-administered drugs includes pain management as a crucial application area, demonstrating the rising demand for patient-friendly and efficient ways to treat both acute and chronic pain. Self-administered analgesics, such as topical creams, oral drugs, and transdermal patches, provide substantial benefits in terms of ease and adaptability, enabling patients to modify their course of treatment as necessary. It is anticipated that the need for self-managed pain management choices will increase due to the growing prevalence of diseases, including neuropathic pain and arthritis, which developments will aid in medication formulations and delivery systems.

Self-administered Drugs Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Self-administered Drugs. The rising prevalence of diabetes, cancer, and bone ailments, as well as the strong demand for self-administered drugs among patients coping with these conditions, are the main drivers of the expansion. Additionally, the government of the biggest economies in the region supports the adoption of various self-administered drugs by offering insurance. Increased USFDA medicine approvals pave the way for new market participants to expand. For instance, the USFDA granted additional clearances to Eli Lilly and Company in June 2020 for their novel rapid-acting insulin, "Lyumjev," which is intended to help adults with type 1 and 2 diabetes improve their glycemic control. An innovative version of insulin lispro is called Lyumjev. The business developed a solution to lower A1C levels and quickly absorb insulin into the bloodstream. Additionally, it regulates elevated blood sugar levels in diabetic persons after meals. Without a prescription, this new indication makes the test available to anybody with or without symptoms.

However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. The prevalence of chronic illnesses, growing healthcare expenses, and easier access to healthcare services are all contributing to the region's growing need for easy and reasonably priced treatment options. The ageing population has increased attention to chronic condition management, which has fueled the use of self-administered drugs. Additionally, retail pharmacies are being encouraged to expand their online drug distribution due to the healthcare infrastructure investments and the expanding medical tourism industry.

Self-administered Drugs Market- Competitive Landscape:

Among the leading companies in the global market for self-administered drugs are Omnicare, SFK Corporation, Johnson & Johnson, Cardinal Health, McKesson Corporation, and others. By implementing several tactics, including partnerships, collaborations, regional expansion, mergers and acquisitions, and new drug development, to remain competitive in the market, the market's participants are also making a substantial contribution to its growth. Furthermore, to increase patient adherence and develop cutting-edge drug delivery methods, businesses in this sector are making significant investments in research and development. The ongoing release of new goods and technology to meet the changing demands of patients and healthcare professionals intensifies the market's competition. For instance, in September 2021, Abbott Laboratories declared that it had acquired Walk Vascular LLC, a manufacturer of medical devices. By expanding Abbott's peripheral vascular portfolio and advancing endovascular therapeutic solutions, this acquisition will enhance patient care.

Recent Development

February 2024: the FDA has given Novartis permission to introduce Xolair(R) (omalizumab). This self-injectable drug can help prevent anaphylaxis and other allergic responses in adults and children with IgE-mediated food allergies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SELF-ADMINISTERED DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Omnicare
  • SFK Corporation
  • Johnson & Johnson
  • Cardinal Health
  • McKesson Corporation
  • Wal-Mart Stores Inc
  • Express Scripts Holding Company
  • CVS Health
  • Walgreens Boots Alliance
  • Rite Aid Corporation
  • Others

GLOBAL SELF-ADMINISTERED DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Injectable Drugs
  • Transdermal Drugs
  • Inhaled Drugs

GLOBAL SELF-ADMINISTERED DRUGS MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Diabetes
  • Cardiovascular
  • Pain Management
  • Hormone Replacement
  • Osteoporosis
  • Others

GLOBAL SELF-ADMINISTERED DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Self-administered Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Self-administered Drugs Market Snippet by Type
    • 2.1.2. Self-administered Drugs Market Snippet by Indication
    • 2.1.3. Self-administered Drugs Market Snippet by Country
    • 2.1.4. Self-administered Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Self-administered Drugs Key Market Trends

  • 3.1. Self-administered Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Self-administered Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Self-administered Drugs Market Opportunities
  • 3.4. Self-administered Drugs Market Future Trends

4. Self-administered Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Self-administered Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Self-administered Drugs Market Landscape

  • 6.1. Self-administered Drugs Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Self-administered Drugs Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Injectable Drugs
    • 7.1.3. Transdermal Drugs
    • 7.1.4. Inhaled Drugs

8. Self-administered Drugs Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
    • 8.1.2. Diabetes
    • 8.1.3. Cardiovascular
    • 8.1.4. Pain Management
    • 8.1.5. Hormone Replacement
    • 8.1.6. Osteoporosis
    • 8.1.7. Others

9. Self-administered Drugs Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Self-administered Drugs Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Self-administered Drugs Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.7. France
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.9. Spain
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.10. United Kingdom
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.11. Russia
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.12. Netherlands
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.13. Sweden
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Self-administered Drugs Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.8. South Korea
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Self-administered Drugs Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Self-administered Drugs Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Self-administered Drugs Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Omnicare
    • 10.2.2. SFK Corporation
    • 10.2.3. Johnson & Johnson
    • 10.2.4. Cardinal Health
    • 10.2.5. McKesson Corporation
    • 10.2.6. Wal-Mart Stores Inc
    • 10.2.7. Express Scripts Holding Company
    • 10.2.8. CVS Health
    • 10.2.9. Walgreens Boots Alliance
    • 10.2.10. Rite Aid Corporation
    • 10.2.11. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us